Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Combination therapy for postmenopausal osteoporosis.

Juliet E Compston¹, Nelson B Watts

¹Department of Medicine, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. jec001@cam.ac.uk

Clinical Endocrinology

|May 29, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The association between 10-year cardiovascular risk and fracture incidence in postmenopausal women: a prospective analysis from the Women's Health Initiative.

Lancet regional health. Americas·2026

Same author

Goal-directed therapy is not as simple as it seems.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Same author

Journal of Bone and Mineral Research (JBMR) 40th anniversary celebration: the third decade (part 2).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Same author

Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

The lancet. Diabetes & endocrinology·2025

Same author

Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025

Same author

Identifying Younger Postmenopausal Women With Osteoporosis Using USPSTF-Recommended Osteoporosis Risk Assessment Tools.

JAMA network open·2025

Combination osteoporosis therapy shows greater bone density gains but lacks fracture reduction evidence. Current data does not support its recommendation due to potential risks and costs.

Area of Science:

Endocrinology
Bone Metabolism
Pharmacology

Background:

Postmenopausal osteoporosis significantly increases fracture risk.
Various agents are available for osteoporosis treatment, with monotherapy being standard.
The efficacy of combining osteoporosis therapies remains unclear.

Purpose of the Study:

To evaluate the benefits and risks of combination therapy versus monotherapy for postmenopausal osteoporosis.
To synthesize evidence from randomized trials on combined osteoporosis treatments.

Main Methods:

Systematic review and meta-analysis of published randomized controlled trials.
Searched MEDLINE database for relevant studies on combination osteoporosis therapies.

Main Results:

Related Experiment Videos

Combination therapy demonstrated superior increases in bone mineral density compared to monotherapy.
Evidence suggests combination therapy may have greater effects on bone turnover markers.
No studies provided sufficient data on fracture reduction to confirm additional benefits.
Potential for increased adverse events, reduced tolerability, and lower adherence with combination therapy.

Conclusions:

While combination therapy improves bone mineral density, evidence for enhanced fracture reduction is lacking.
Concerns exist regarding cost, adverse events, tolerability, and adherence.
Over-suppression of bone turnover with combined antiresorptive therapy may negatively impact bone strength.
Current evidence does not support the routine use of combination therapy for osteoporosis.